You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Boxer Capital | . | . | . | . | . | (9). 5.5% |
Boxer Asset Management Inc | . | . | . | . | . | (9). 5.5% |
Joe Lewis | . | . | . | . | . | (9). 5.5% |
Page 1 of 7 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
MACROGENICS,
INC.
(Name of Issuer)
Common Stock, par value $ $0.01 per share
(Title of Class of Securities)
556099109
(CUSIP Number)
May 31, 2017
(Date of Event which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐
Rule 13d-1(d)
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
Follow Macrogenics Inc (NASDAQ:MGNX)
Follow Macrogenics Inc (NASDAQ:MGNX)
Page 2 of 7 – SEC Filing
CUSIP No. 556099109
1 | Name of Boxer Capital, LLC | |||||
2 | Check the appropriate box if a member (a) ☐ (b) ☒ | |||||
3 | SEC use only. | |||||
4 | Citizenship or place of Delaware | |||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | Sole voting power. -0- | ||||
6 | Shared voting power. 1,987,000 | |||||
7 | Sole dispositive power. -0- | |||||
8 | Shared dispositive power. 1,987,000 | |||||
9 | Aggregate amount beneficially owned by each reporting person. 1,987,000 | |||||
10 | Check box if the aggregate amount in ☐ | |||||
11 | Percent of class represented by amount 5.5%* | |||||
12 | Type of reporting person OO |
* | Based on 36,112,593 shares of common stock reported to be outstanding on the Issuers Prospectus Supplement filed with the Securities and Exchange Commission on April 27, 2017. |
Follow Macrogenics Inc (NASDAQ:MGNX)
Follow Macrogenics Inc (NASDAQ:MGNX)
Page 3 of 7 – SEC Filing
CUSIP No. 556099109
1 | Name of Boxer Asset Management Inc. | |||||
2 | Check the appropriate box if a member (a) ☐ (b) ☒ | |||||
3 | SEC use only. | |||||
4 | Citizenship or place of Bahamas | |||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | Sole voting power. -0- | ||||
6 | Shared voting power. 1,987,000 | |||||
7 | Sole dispositive power. -0- | |||||
8 | Shared dispositive power. 1,987,000 | |||||
9 | Aggregate amount beneficially owned by each reporting person. 1,987,000 | |||||
10 | Check box if the aggregate amount in ☐ | |||||
11 | Percent of class represented by amount 5.5%* | |||||
12 | Type of reporting person CO |
* | Based on 36,112,593 shares of common stock reported to be outstanding on the Issuers Prospectus Supplement filed with the Securities and Exchange Commission on April 27, 2017. |
Follow Macrogenics Inc (NASDAQ:MGNX)
Follow Macrogenics Inc (NASDAQ:MGNX)
Page 4 of 7 – SEC Filing
CUSIP No. 556099109
1 | Name of Joe Lewis | |||||
2 | Check the appropriate box if a member (a) ☐ (b) ☒ | |||||
3 | SEC use only. | |||||
4 | Citizenship or place of United Kingdom | |||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | Sole voting power. -0- | ||||
6 | Shared voting power. 1,987,000 | |||||
7 | Sole dispositive power. -0- | |||||
8 | Shared dispositive power. 1,987,000 | |||||
9 | Aggregate amount beneficially owned by each reporting person. 1,987,000 | |||||
10 | Check box if the aggregate amount in ☐ | |||||
11 | Percent of class represented by amount 5.5%* | |||||
12 | Type of reporting person IN |
* | Based on 36,112,593 shares of common stock reported to be outstanding on the Issuers Prospectus Supplement filed with the Securities and Exchange Commission on April 27, 2017. |
Follow Macrogenics Inc (NASDAQ:MGNX)
Follow Macrogenics Inc (NASDAQ:MGNX)
Page 5 of 7 – SEC Filing
Item 1(a). Name of Issuer:
Macrogenics, Inc. (the Issuer)
Item 1(b). Address of Issuers Principal Executive Offices:
9704 Medical Center Drive
Rockville, MD 20850
Item 2(a). Name of
Person Filing:
This Schedule 13G is jointly filed by Boxer Capital, LLC (Boxer Capital), Boxer Asset Management Inc.
(Boxer Management) and Joe Lewis (together with Boxer Capital and Boxer Management, the Reporting Persons). Boxer Management is the managing member and majority owner of Boxer Capital. Joe Lewis is the sole indirect
beneficial owner of and controls Boxer Management.
Item 2(b). Address of Principal Business Office, or, if none, Residence:
The principal business address of Boxer Capital is: 11682 El Camino Real, Suite 320, San Diego, CA 92130. The principal business address of
Boxer Management and Joe Lewis is: Cay House, EP Taylor Drive N7776, Lyford Cay, New Providence, Bahamas.
Item 2(c). Citizenship:
Boxer Capital is a limited liability company organized under the laws of Delaware. Boxer Management is a corporation organized under the laws
of the Bahamas. Joe Lewis is a citizen of the United Kingdom.
Item 2(d). Title of Class of Securities:
Common Stock, par value $0.01 per share (the Common Stock).
Item 2(e). CUSIP Number:
556099109
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
Not applicable.
Item 4. Ownership.
(a) | Amount beneficially owned: |
The Reporting Persons beneficially own 1,987,000 shares of Common
Stock.
(b) | Percent of class: |
The shares of Common Stock beneficially owned by the Reporting Persons
represents 5.5%* of the Issuers outstanding shares of Common Stock.
(c) | Number of shares as to which such person has: |
(i) | Sole power to vote or direct the vote: |
None of the Reporting Persons has the sole power to
vote or to direct the vote of any shares of Common Stock the Reporting Persons beneficially own.
Follow Macrogenics Inc (NASDAQ:MGNX)
Follow Macrogenics Inc (NASDAQ:MGNX)
Page 6 of 7 – SEC Filing
(ii) | Shared power to vote or to direct the vote: |
The Reporting Persons have shared power to vote
or to direct the vote of the 1,987,000 shares of Common Stock they beneficially own.
(iii) | Sole power to dispose or to direct the disposition of: |
None of the Reporting Persons has the
sole power to dispose or to direct the disposition of any of the shares of Common Stock the Reporting Persons beneficially own.
(iv) | Shared power to dispose or to direct the disposition of: |
The Reporting Persons have shared
power to dispose or to direct the disposition of the 1,987,000 shares of Common Stock they beneficially own.
* | Based on 36,112,593 shares of common stock reported to be outstanding on the Issuers Prospectus Supplement filed with the Securities and Exchange Commission on April 27, 2017. |
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of
More than Five Percent on Behalf of Another Person.
Only Boxer Capital has the right to receive dividends and the proceeds from the
sale of the shares of Common Stock held by Boxer Capital. See Item 4 above.
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of
Dissolution of Group.
Not applicable.
Item 10. Certification.
(c) By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Exhibits
1 | Joint Filing Agreement, dated June 12, 2017, among the Reporting Persons. |
Follow Macrogenics Inc (NASDAQ:MGNX)
Follow Macrogenics Inc (NASDAQ:MGNX)
Page 7 of 7 – SEC Filing
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
June 12, 2017
BOXER CAPITAL, LLC | ||
By: | /s/ Aaron I. Davis | |
Name: | Aaron I. Davis | |
Title: | Chief Executive Officer | |
BOXER ASSET MANAGEMENT INC. | ||
By: | /s/ Jason Callender | |
Name: | Jason Callender | |
Title: | Director | |
JOSEPH C. LEWIS | ||
/s/ Joseph C. Lewis | ||
Joseph C. Lewis, Individually |